Equality in Medicare and Medicaid Treatment Act of 2020

To amend title XI of the Social Security Act to improve access to care for all Medicare and Medicaid beneficiaries through models tested under the Center for Medicare and Medicaid Innovation, and for other purposes. 1. Short title This Act may be cited as the Equality in Medicare and Medicaid Treatment Act of 2020 2. Improving access to care for Medicare and Medicaid beneficiaries Section 1115A of the Social Security Act ( 42 U.S.C. 1315a (1) in subsection (a)(3), in the first sentence— (A) by inserting the Office of Minority Health of the Centers for Medicare & Medicaid Services, the Federal Office of Rural Health Policy, the Office on Women’s Health, and other representatives of (B) by inserting , the causes of health disparities and social determinants of health, medicine (2) in subsection (b)— (A) in paragraph (2)— (i) in subparagraph (A)— (I) in the second sentence, by inserting , as well as improving access to care received by individuals receiving benefits under such title, applicable title (II) by inserting after the first sentence, the following new sentence: Prior to model selection, the Secretary shall consult with the Office of Minority Health of the Centers for Medicare & Medicaid Services, the Federal Office of Rural Health Policy, and the Office on Women’s Health to ensure that models under consideration address health disparities and social determinants of health as appropriate for populations to be cared for under the model. (III) by adding at the end the following new sentence: The models selected under this subparagraph shall include the social determinants of health payment model described in subparagraph (D), the testing of which shall begin not later than December 31, 2021. (ii) in subparagraph (C), by adding at the end the following new clauses: (ix) Whether the model will affect access to care from providers and suppliers caring for high risk patients or operating in underserved areas. (x) Whether the model has the potential to produce reductions in minority and rural health disparities. ; and (iii) by adding at the end the following new subparagraph: (D) Social determinants of health payment model (i) In general The social determinants of health payment model described in this subparagraph is a payment model that tests each of the payment and service delivery innovations described in clause (ii) in a region determined appropriate by the Secretary. (ii) Payment and service delivery innovations described For purposes of clause (i), the payment and service delivery innovations described in this clause are the following: (I) Payment and service delivery innovations for behavioral health services, focusing on gathering actionable data to address the higher costs associated with beneficiaries with diagnosed behavioral conditions. (II) Payment and service delivery innovations targeting conditions or comorbidities of individuals entitled or enrolled under the Medicare program under title XVIII and enrolled under a State plan under the Medicaid program under title XIX to increase capacity in underserved areas. (III) Payment and service delivery innovations targeted on Medicaid-eligible pregnant and postpartum women, up to one year after delivery. ; and (B) in paragraph (4)(A)— (i) in clause (i) at the end, by striking and (ii) in clause (ii), at the end, by striking the period and inserting ; and (iii) by adding at the end the following new clause: (iii) the extent to which the model improves access to care or the extent to which the model improves care for high risk patients, patients from racial or ethnic minorities, or patients in underserved areas. ; (3) in subsection (c)— (A) in paragraph (2), by striking at the end and (B) by redesignating paragraph (3) as paragraph (4); (C) by inserting after paragraph (2) the following new paragraph: (3) the Office of Minority Health of the Centers for Medicare & Medicaid Services certifies that such expansion will not reduce access to care for low-income, minority, or rural beneficiaries; and ; (D) in paragraph (4), as redesignated by subparagraph (B), by inserting before the period at the end the following: nor increase health disparities experienced by low-income, minority, or rural beneficiaries (E) in the matter following paragraph (4), as redesignated by subparagraph (B), by inserting , improve access to care, care (4) in subsection (g)— (A) by inserting (or, beginning with 2022, once every year thereafter) thereafter (B) by adding at the end the following new sentence: For reports for 2022 and each subsequent year, each such report shall include information on the following: (1) The extent and severity of minority and rural health disparities in Medicare and Medicaid beneficiaries. (2) The interventions that address social determinants of health in payment models selected by the Center for Medicare and Medicaid Innovation for testing. (3) The interventions that address social determinants of health in payment models not selected by the Center for Medicare and Medicaid Innovation for testing. (4) The effectiveness of interventions in mitigating negative health outcomes and higher costs associated with social determinants of health within models selected by the Center for Medicare and Medicaid Innovation for testing. (5) Changes in disparities among minorities and Medicare and Medicaid beneficiaries in underserved areas that are attributable to provider and supplier participation in a Phase II model. (6) In consultation with the Comptroller General of the United States, estimated Federal savings achieved through the reduction of rural and minority health disparities. (7) Other areas determined appropriate by the Secretary. .

Summary: Equality in Medicare and Medicaid Treatment Act of 2020 This bill requires the Center for Medicare and Medicaid Innovation to test a payment model that addresses social determinants of health and health disparities, particularly with respect to minorities, underserved areas, and high-risk individuals. The bill also generally incorporates consideration of such factors into the selection, implementation, and evaluation of other models, including the decision as to whether to expand a model's duration and scope.